Keyphrases
Prostate Cancer
62%
Prostate Cancer Risk
38%
Transrectal Biopsy
25%
Prostate-specific Antigen
23%
Cancer Registry
22%
Prostate Cancer Screening
21%
Denmark
20%
Prostate
19%
Population Analysis
17%
Prostate Cancer Patients
13%
Radical Prostatectomy
12%
Nonmalignant
12%
Registry Study
11%
Subnational Analysis
11%
Androgen Deprivation Therapy
11%
Depression Risk
11%
Nationwide Registry
11%
Confidence Interval
10%
Cumulative Incidence
9%
Initial Biopsy
9%
Cause of Death
8%
Transrectal Ultrasound
8%
Re-biopsy
8%
Salvage Radiation
7%
Population-based Study
7%
Prostate Biopsy
7%
Newly Diagnosed
6%
20-year Period
6%
National Database
6%
Danish Population
6%
Localized Prostate Cancer
6%
Endocrine Therapy
6%
Active Surveillance
6%
Hazard Ratio
6%
Ultrasound-guided
6%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
6%
Working Diagnosis
6%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
6%
Population-based Setting
6%
Positive Surgical Margin
6%
Cancer-free
5%
Prostate-specific Antigen Testing
5%
Suicide Risk
5%
Age at Death
5%
Guided Biopsy
5%
Incidental Prostate Cancer
5%
Diagnostic Age
5%
Cancer Incidence
5%
Cancer Mortality Rates
5%
TRUS Biopsy
5%
Medicine and Dentistry
Prostate Cancer
100%
Biopsy
51%
Transrectal Ultrasonography
32%
Cancer Mortality
32%
Prostate Specific Antigen
25%
Diagnosis
21%
Cancer Registry
20%
Prostate Cancer Diagnosis
19%
Prostatectomy
12%
Disease
11%
Systematic Review
11%
Prostate Biopsy
10%
Androgen Deprivation Therapy
9%
Cumulative Incidence
9%
Malignant Neoplasm
6%
Observational Study
6%
Mortality Rate
6%
Cancer Incidence
6%
Surgical Margin
6%
Transurethral Resection
6%
Histopathology
6%
Gleason Score
5%
Hazard Ratio
5%
Vitamin D
5%
Androgen
5%
Cystectomy
5%
Systematized Nomenclature of Medicine
5%
Radiation Therapy
5%
Antibiotics
5%
Antibiotic Prophylaxis
5%
